FDA Extends Comment Period for Proposed Rule on N-Nitrosonornicotine Limit in Smokeless Tobacco Products

Summary

The Food and Drug Administration (FDA) is extending the comment period for its proposed rule, which aims to establish a limit on N-nitrosonornicotine (NNN) in finished smokeless tobacco products, in response to requests for an extension. The agency is also addressing a typographical error in a formula and reviewing the rule consistent with a regulatory freeze pending review.